Ranked #1,138 of 1,373 · scores higher than 17% of peers · safety percentile 17
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)
137 peers with a safety percentile of 10–19, including DNA · Click a bar to see the companies
Why “Higher relative risk”?
The measures below combine into a safety percentile of 17 among Healthcare companies. It is relative: 67 or more is lower relative risk, 33–66 moderate, below 33 higher.
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
▼a share price that has swung more with the market: weaker than 93% of peers. Beta: 1.79 vs peer median 0.63
▼more borrowing relative to shareholders' equity: weaker than 84% of peers. Debt / equity: 0.96× vs peer median 0.22×
▲more short-term assets to cover bills due within a year: stronger than 70% of peers. Current ratio: 4.57× vs peer median 2.59×
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
Metric by metric
Position: dot = DNA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
